Danaher Co. (NYSE:DHR - Free Report) - Analysts at Zacks Research dropped their Q1 2024 EPS estimates for shares of Danaher in a report issued on Wednesday, April 17th. Zacks Research analyst R. Department now anticipates that the conglomerate will post earnings of $1.72 per share for the quarter, down from their previous estimate of $1.74. The consensus estimate for Danaher's current full-year earnings is $7.62 per share. Zacks Research also issued estimates for Danaher's Q2 2024 earnings at $1.62 EPS, Q3 2024 earnings at $1.90 EPS, Q4 2024 earnings at $2.34 EPS, Q3 2025 earnings at $2.14 EPS, Q4 2025 earnings at $2.42 EPS, FY2025 earnings at $8.47 EPS, Q1 2026 earnings at $2.25 EPS and FY2026 earnings at $10.01 EPS.
A number of other analysts also recently issued reports on DHR. Barclays boosted their price objective on shares of Danaher from $240.00 to $260.00 and gave the company an "equal weight" rating in a report on Wednesday, April 10th. Royal Bank of Canada increased their target price on shares of Danaher from $254.00 to $282.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 31st. Raymond James increased their target price on shares of Danaher from $240.00 to $270.00 and gave the company an "outperform" rating in a report on Wednesday, January 31st. Citigroup lifted their target price on shares of Danaher from $255.00 to $280.00 and gave the stock a "buy" rating in a research note on Wednesday, January 31st. Finally, StockNews.com lowered shares of Danaher from a "buy" rating to a "hold" rating in a research report on Wednesday, January 31st. Six research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $268.27.
Read Our Latest Report on DHR
Danaher Stock Performance
Shares of DHR stock traded down $3.02 during midday trading on Thursday, hitting $236.37. 4,261,040 shares of the company were exchanged, compared to its average volume of 2,727,856. The firm has a market capitalization of $175.04 billion, a P/E ratio of 36.99, a PEG ratio of 3.65 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.68. The firm's 50 day moving average price is $249.09 and its two-hundred day moving average price is $229.90. Danaher has a 52 week low of $182.09 and a 52 week high of $259.00.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.18. The company had revenue of $6.41 billion for the quarter, compared to analyst estimates of $6.10 billion. Danaher had a net margin of 17.26% and a return on equity of 12.25%. Danaher's revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period in the previous year, the business earned $2.87 EPS.
Danaher Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be issued a $0.27 dividend. This is an increase from Danaher's previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. The ex-dividend date is Wednesday, March 27th. Danaher's payout ratio is presently 16.90%.
Insider Activity at Danaher
In other Danaher news, SVP Daniel Raskas sold 23,757 shares of the business's stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the transaction, the senior vice president now directly owns 38,102 shares in the company, valued at $9,601,704. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of the firm's stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the sale, the senior vice president now directly owns 4,244 shares of the company's stock, valued at approximately $1,029,891.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Daniel Raskas sold 23,757 shares of the firm's stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the sale, the senior vice president now directly owns 38,102 shares of the company's stock, valued at $9,601,704. The disclosure for this sale can be found here. Insiders sold 32,957 shares of company stock worth $8,265,802 over the last three months. 11.10% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Danaher
A number of hedge funds have recently modified their holdings of the business. Banco Santander S.A. purchased a new position in Danaher during the 3rd quarter valued at about $683,000. First Citizens Bank & Trust Co. raised its position in Danaher by 0.6% in the 4th quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate's stock valued at $6,156,000 after purchasing an additional 149 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Danaher by 48.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 296,996 shares of the conglomerate's stock valued at $68,707,000 after purchasing an additional 96,395 shares in the last quarter. Parkside Financial Bank & Trust raised its position in Danaher by 4.8% in the 3rd quarter. Parkside Financial Bank & Trust now owns 3,080 shares of the conglomerate's stock valued at $764,000 after purchasing an additional 142 shares in the last quarter. Finally, Keybank National Association OH raised its position in Danaher by 0.5% in the 3rd quarter. Keybank National Association OH now owns 553,155 shares of the conglomerate's stock valued at $137,238,000 after purchasing an additional 2,567 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
About Danaher
(
Get Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
